CurebaseDemo
    New ArticleRead Article →

    What Is ePRO? 2026 Guide to Patient-Reported Outcomes

    what is epro

    If you work in clinical research, you’ve likely heard the term ePRO. But what is ePRO, really? In short, an electronic patient reported outcome (ePRO) is health information that comes directly from the patient, captured digitally. Instead of using a traditional paper diary, patients use tools like smartphone apps, websites, or telephone systems to report on their symptoms, quality of life, and overall health experiences.

    This shift from paper to pixels is more than just a modern convenience. The implementation of ePRO is a fundamental change in how we gather the patient’s perspective in clinical trials, leading to better data and a more complete understanding of how a treatment truly affects a person’s life.

    The Core Purpose of ePRO in Clinical Trials

    The main reason clinical trials use ePRO is to capture the patient’s unique perspective. Some of the most important outcomes in a study, like pain severity, fatigue, or mood, are things only the patient can report. These experiences might not show up in lab tests or scans.

    By collecting ePRO data, researchers can evaluate how effective a treatment is and what side effects it causes, all from the patient’s point of view in their real world environment. A new drug might produce great lab results, but if it comes with severe lifestyle disruptions that only a patient can describe, that’s a critical piece of the puzzle. Sometimes, patient reported outcomes are the only way to tell two similar drugs apart, for instance, if one significantly improves a patient’s quality of life.

    Ultimately, ePRO ensures the patient’s voice is a central part of a trial’s results, giving regulators and doctors a more holistic view of a treatment’s risks and benefits.

    The Old Way vs. The New Way

    For decades, patient feedback was collected with pen and paper. While it was the only option, this method came with significant drawbacks that modern ePRO systems were designed to solve.

    The Problem with Paper Diaries

    Traditional paper diaries suffer from some well known limitations that can compromise data quality.

    • Recall Bias and Back-filling: Patients often forget to fill out their diaries on schedule. Instead, they try to fill in several days of data from memory right before a clinic visit, a phenomenon sometimes called “parking lot syndrome”. These retrospective entries are often inaccurate. One study found that while patients claimed 90% compliance with paper diaries, time tracking revealed only 11% of entries were actually completed on time.
    • Missing Data and Illegibility: It’s easy for patients to accidentally skip questions, misread instructions, or write answers that are impossible to read. There are no built in checks to catch these mistakes as they happen, a problem that modern ePRO solves.
    • Transcription Errors: Once the paper forms get to the clinic, a staff member has to manually type all the data into a database. This extra step introduces the risk of human error and significantly delays access to the information.

    The Benefits of Going Digital with ePRO

    Switching to electronic collection addresses the core problems of paper diaries and offers major advantages for data quality and trial efficiency.

    • Improved Data Accuracy: ePRO systems eliminate many manual errors. Entries are time stamped, legible, and checked for completeness in real time, which dramatically reduces missing data and mistakes.
    • Higher Patient Compliance: Patients find digital ePRO diaries more convenient and are more likely to complete them on time, especially with automated reminders. Studies have shown that while paper diary compliance can be low, electronic surveys often achieve 90% to 97% patient compliance.
    • Real Time Monitoring: As soon as a patient submits an entry, the data is available for the study team to review. This allows for faster decision making and lets teams address safety concerns or data trends without waiting weeks for paper forms to be collected and transcribed.
    • Better Patient Engagement: Automated push notifications, emails, or text messages can remind participants to complete their questionnaires. This interaction keeps patients more involved and on track with the study schedule.

    Modern eClinical platforms are designed to maximize these benefits by integrating ePRO with other trial management tools. Explore how Curebase improves data quality and patient engagement with its AI native platform.

    What is ePRO in Practice? A Closer Look

    Understanding what is epro involves looking at the specific tools and methods used to collect patient data electronically. These tools are designed to be user friendly and integrate seamlessly into a patient’s daily life.

    The Electronic Diary (eDiary) Explained

    An electronic diary, or eDiary, is the digital version of a traditional patient diary and a common method for ePRO data collection. Using a device, patients can regularly log information about their health, such as daily symptom ratings or medication intake. This allows for frequent data capture in the patient’s normal environment. For example, a trial participant might use a smartphone app to answer a few questions about their pain level each evening. Because the entries are time stamped and guided by software, eDiaries ensure data is captured correctly and on time. In one trial, using an eDiary resulted in a verified 94% compliance rate for on schedule entries.

    How ePRO Data is Collected: Methods and Devices

    ePRO systems are flexible and can use several methods to collect data, making participation accessible to a wider range of people.

    • Screen Based Devices: The most common method involves a software application on a smartphone, tablet, or a web portal on a computer. These apps are intuitive and can often work offline, syncing data later.
    • Interactive Voice Response (IVR): Patients receive automated phone calls and respond to questions by pressing keys on their phone or speaking their answers. IVR is a great option for patients who may not have internet access or feel comfortable with apps.
    • SMS Text Messaging: The system can send survey questions via text message, and patients can reply with simple, coded responses.

    A trial might even use a hybrid approach. For example, one oncology study found that while 82% of participants chose a web based interface, about 17% preferred using an IVR telephone system. Interestingly, the patients who opted for the phone were older on average (around 70 years old) compared to those using the web (around 60 years old), showing how offering multiple options can improve inclusivity.

    On-Site vs. At Home: Site Based ePRO Administration

    Site based ePRO is when patients complete their electronic assessments during a visit to the clinical trial site. They might use a tablet or a computer kiosk provided by the clinic staff. This is different from remote ePRO, common in decentralized clinical trials, where patients make entries from home on their own schedule.

    This on site approach is useful for patients who don’t have a suitable device at home or for critical assessments that require supervision. A major benefit is that data is entered directly into the electronic system, which eliminates the need for staff to transcribe answers from paper, saving time and preventing errors.

    Key Features That Make ePRO Systems Work

    Modern ePRO platforms are packed with features designed to ensure high quality data, protocol compliance, and a smooth patient experience.

    • Time Stamped Entries: Every single response is automatically stamped with the exact date and time it was submitted. This prevents back filling and provides a clear audit trail.
    • Data Validation and Edit Checks: The software can enforce rules to improve accuracy. It can prevent missing answers, catch illogical responses (like entering “15” on a 1 to 10 scale), and prompt the patient to correct them immediately.
    • Branching Logic (Skip Patterns): The system intelligently shows only relevant questions. If a patient answers “No” to having a certain symptom, the follow up questions about that symptom are automatically skipped, making the questionnaire shorter and more personalized.
    • Reminders and Alerts: Automated reminders can be sent via push notification, text, or email to prompt patients when it’s time to make an entry. This simple feature dramatically improves compliance rates.
    • Security and Compliance: ePRO systems are built to meet strict regulatory requirements like 21 CFR Part 11 and GDPR. This includes secure user authentication, data encryption, and audit trails that track all changes.

    Platforms like Curebase’s ePRO software leverage these features to guide patients through study protocols with an intuitive mobile app, ensuring high data fidelity from the start.

    The Human Side of ePRO

    Technology is only effective if people are willing and able to use it. Fortunately, the evidence shows that ePRO is not only functional but also well received by the people who matter most: the patients.

    Do Patients Actually Prefer ePRO?

    The answer is overwhelmingly yes. Studies show that patients generally find ePRO easier and more convenient than keeping a paper diary. This holds true even for older adults and people with limited computer experience.

    In one study of over 300 cancer patients, 83% said they preferred completing questionnaires electronically over paper. Many participants appreciate not having to carry a booklet around, getting automatic reminders, and the privacy of entering data on their own device.

    Is Digital Data as Good as Paper?

    A critical question is whether moving a questionnaire from paper to a screen changes how patients respond. Decades of research have shown that for the vast majority of cases, the answer is no. A large 2015 systematic review concluded that well designed electronic and paper based PROs produce equivalent scores across a wide range of conditions and devices.

    This means trial teams can be confident that an electronic survey is measuring the same thing as its validated paper counterpart, but with all the added benefits of digital data capture.

    Understanding the ePRO Landscape

    As you learn more about what is epro, you may encounter a few related terms and concepts. Clarifying them can help you navigate the world of eClinical technology.

    ePRO vs. eCOA: What’s the Difference?

    eCOA, or electronic Clinical Outcome Assessment, is a broad term for any clinical outcome data captured electronically. ePRO is a specific type of eCOA.

    Think of it this way: eCOA is the umbrella category that includes data from clinicians (ClinROs), observers like a parent or caregiver (ObsROs), and patients (PROs). So, all ePRO is eCOA, but not all eCOA is ePRO. If a trial only collects patient self reports digitally, you would call it ePRO. If it also includes digital forms filled out by doctors, you would refer to the whole system as eCOA.

    BYOD vs. Provisioned Devices: Choosing the Right Approach

    When implementing ePRO, a study must decide how patients will access the software.

    • BYOD (Bring Your Own Device): Patients use their personal smartphone or tablet. This is convenient, reduces study costs, and allows patients to use a device they are already comfortable with.
    • Provisioned Device: The study provides each participant with a device, like a pre configured smartphone, specifically for the trial. This gives the study team full control over the software and hardware environment.

    Today, the best practice is a hybrid model. This approach allows most patients to use their own device (BYOD) for convenience, while offering a provisioned device to anyone who needs one. This ensures no one is excluded from the trial for not owning a compatible smartphone. The successful use of BYOD in large scale COVID 19 vaccine trials has given regulators and sponsors great confidence in this flexible model.

    Curebase supports a flexible hybrid approach, aligning with FDA guidance to ensure broad and diverse participation. Learn more about eConsent as a complementary workflow.

    ePRO in a Regulated World

    For ePRO data to be used in support of a new drug or device approval, it must meet strict regulatory standards. This involves both the technology itself and the content of the questionnaires.

    The ePRO platform must comply with technical regulations like the FDA’s 21 CFR Part 11, which governs electronic records and signatures. This ensures the data is authentic, secure, and has a verifiable audit trail.

    Additionally, for global trials, the questionnaires must undergo linguistic validation. This is a rigorous process of translating and culturally adapting the instrument for each language and region. It ensures that a question about “feeling blue” is translated in a way that is conceptually equivalent to native speakers in France or Japan, not just literally translated. Regulatory agencies like the FDA and EMA require thorough documentation of this process to ensure the data collected worldwide is consistent and reliable.

    Frequently Asked Questions about ePRO

    What is an ePRO system?

    An ePRO system is the complete software platform used to collect, manage, and analyze electronic patient reported outcomes. This includes the patient facing mobile app or website, as well as the portals, dashboards, and integrated EDC used by researchers and clinicians to monitor the data in real time.

    What is the main benefit of using ePRO over paper diaries?

    The primary benefit is significantly higher data quality. ePRO improves accuracy by eliminating transcription errors, reduces missing data through real time checks, and ensures timely entries with time stamping and reminders, overcoming the key weaknesses of paper.

    Is ePRO difficult for older patients to use?

    No, studies consistently show that with good design and clear instructions, older adults can successfully use ePRO tools and often prefer them to paper. Offering different options, like a simple app or a telephone based system, helps ensure accessibility for everyone.

    What is the difference between ePRO and eCOA?

    ePRO refers specifically to data reported directly by the patient. eCOA is a broader term that includes ePRO as well as other types of electronically captured clinical data, such as assessments completed by a clinician or an observer.

    Can patients use their own phones for ePRO?

    Yes, this is known as the “Bring Your Own Device” or BYOD model. It is a very common and popular approach because it is convenient for patients and cost effective for studies. Most modern trials offer BYOD as the primary option.